Pilocarpine Lollipops After Radiation Therapy

Some patients may experience persistent dry mouth after radiation therapy, particularly when treatment affects the salivary glands. Xerostomia can interfere with speaking, eating, swallowing, and oral comfort. Pilocarpine may stimulate saliva production in selected patients when sufficient salivary gland function remains. A healthcare provider may determine whether pilocarpine is appropriate based on an individual’s condition and medical history. In certain situations, a compounded dosage form such as a pilocarpine lollipop may be considered. Patients should discuss persistent dry mouth with their healthcare provider before starting any medication. Learn more about pilocarpine lollipops and xerostomia management.